Sanofi India Ltd (SANOFI) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 664761,
    "name": "Sanofi India",
    "stock_name": "Sanofi India",
    "full_name": "Sanofi India Ltd",
    "name_url": "stocks-analysis/sanofi-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,024.00",
    "chg": -10.95,
    "chgp": "-0.27%",
    "dir": -1,
    "prev_price": "4,034.95",
    "mcapval": "9,373.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500674,
    "symbol": "SANOFI",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE058A01010",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "26.72 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sanofi-india-664761-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Sanofi India’s Evaluation Metrics Revised Amidst Challenging Market Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanofi-india-downgraded-to-sell-by-marketsmojo-amid-weak-financial-and-technical-trends-3733125",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanofiIndia_mojoScore_3733125.png",
        "date": "2025-11-27 10:06:18",
        "description": "Sanofi India has experienced a revision in its evaluation metrics reflecting a shift in market assessment, influenced by recent financial trends and technical indicators. The pharmaceutical company’s performance data and sector context provide insight into the factors shaping this change."
      },
      {
        "title": "Why is Sanofi India falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sanofi-india-fallingrising-3726759",
        "imagepath": "",
        "date": "2025-11-25 00:51:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>On 24 November, Sanofi India’s shares closed at ₹4,398, down ₹111.3 or 2.47% from the previous session. This decline continues a five-day losing streak during which the stock has dropped 4.75%. Intraday, the share price touched a low of ₹4,370, marking a 3.09% dip. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure. Furthermore, the stock is trading below all key moving averages – the 5-day, 20-day, 50-day, 100-day, and 200-day – underscoring a bearish technical trend.</p>\n<p>Investor participation appears to be waning, with delivery volumes on 21 November falling by 26.06% compared to the five-day average. This decline in investor engagement may be contri..."
      },
      {
        "title": "Sanofi India Hits 52-Week Low, Trading at Rs 33.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanofi-india-hits-52-week-low-trading-at-rs-3305-3690254",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanofiIndia_priceRelatedfactors_3690254.png",
        "date": "2025-11-11 18:01:57",
        "description": "Sanofi India has reached a 52-week low, reflecting a challenging period with a significant decline over the past year. The stock is trading below key moving averages, although it maintains a high dividend yield and strong management efficiency. Long-term growth prospects appear subdued amid negative sales and profit trends."
      }
    ],
    "total": 164,
    "sid": "664761",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/sanofi-india-664761"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Jan-2026",
      "details": "Please find enclosed copies of the Notice to Shareholders of the Company published today i.e. 9th January 2026 in newspapers Business Standard (English) and Sakal (Marathi).",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "05-Jan-2026",
      "details": "Please find enclosed Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the period ended 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015",
      "datetime": "30-Dec-2025",
      "details": "Please find enclosed disclosure received under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sanofi India Ltd has declared <strong>750%</strong> dividend, ex-date: 07 Nov 25",
          "dt": "2025-11-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sanofi India’s Evaluation Metrics Revised Amidst Challenging Market Performance

2025-11-27 10:06:18

Sanofi India has experienced a revision in its evaluation metrics reflecting a shift in market assessment, influenced by recent financial trends and technical indicators. The pharmaceutical company’s performance data and sector context provide insight into the factors shaping this change.

Why is Sanofi India falling/rising?

2025-11-25 00:51:01

Recent Price Movement and Market Performance On 24 November, Sanofi India’s shares closed at ₹4,398, down ₹111.3 or 2.47% from the previous session. This decline continues a five-day losing streak during which the stock has dropped 4.75%. Intraday, the share price touched a low of ₹4,370, marking a 3.09% dip. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure. Furthermore, the stock is trading below all key moving averages – the 5-day, 20-day, 50-day, 100-day, and 200-day – underscoring a bearish technical trend. Investor participation appears to be waning, with delivery volumes on 21 November falling by 26.06% compared to the five-day average. This decline in investor engagement may be contri...

Sanofi India Hits 52-Week Low, Trading at Rs 33.05

2025-11-11 18:01:57

Sanofi India has reached a 52-week low, reflecting a challenging period with a significant decline over the past year. The stock is trading below key moving averages, although it maintains a high dividend yield and strong management efficiency. Long-term growth prospects appear subdued amid negative sales and profit trends.

View All News